Li Guo, Ph.D.
Release time:
2025-01-20 22:02
SVP, Head of R&D
20 years’ experience in novel therapeutic biologics discovery & development for treating cancer and autoimmune & inflammation diseases
Led the R&D team and accomplished FIC and BIC antibody drugs development with two programs receiving IND approval in both China and the US
Principle Scientist & Global Project Leader at Novo Nordisk China R&D Center, and Scientist at Organon Research Center ( Shering-Plough, US)
Postdoctoral Fellow at Harvard University
Ph.D. from Chinese Academy of Sciences
Previous Page
Next Page
Previous Page
Next Page
Related News